Skip to Main Content

Paper Details

Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study.
Clin Cancer Res
14
2022
Author NameAffiliation
Antonio JimenoUniversity of Colorado Cancer Center
Ezra E W CohenUniversity of California San Diego, Moores Cancer Center
  • 1 - 2

Datasets

Release 1.2